Global Cancer Technology, Inc holds licenses to patents and Intellectual Property for 5 separate and unique medical technologies. The Company will commercialize these technologies by setting up subsidiary companies. The Company seeks to fund each of these technologies through the subsidiary that is formed. Global Cancer Technology, Inc owns a majority of each subsidiary.

Our Team

Tom Silberg

Tom Silberg

Senior Healthcare Advisor

Endre Takcas

Endre Takcas

Chief Technology Officer